Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

IMDRF releases three new proposed guidance documents. FDA is accepting comments on its plans to accept electronic submissions for device recalls. More regulatory news.

You may also be interested in...

Research Briefs: Underreporting Robot Surgery Events; AFib, Lung-Cancer Studies

A review of court records and media reports finds several robotic surgery adverse event reports that do not appear in FDA’s public records. DECAAF shows DE-MRI can guide atrial fibrillation ablation. The PanCan study identifies predictors of lung cancer.

Pressure On Hysterectomy Procedures Challenges Intuitive’s Financials

The robotic surgical instrument company attributes the decline in capital equipment sales to disappointing growth in benign gynecology procedures performed in the U.S. with the firm’s flagship da Vinci robot.

Medtronic Petitions FCC To Expand Medical Testing License Eligibility

In a petition to the Federal Communications Commission, Medtronic asked the agency to expand medical testing license eligibility to sponsors of clinical trials, as well as clarify its policy on manufacturers recovering costs for clinical studies.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts